CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia
Clinical trial NCT07008872 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07008872
- Sponsor
- Qi deng
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.